Preventive CGRP ligand monoclonal antibody therapy in refractory adult-onset migraine- associated cyclic vomiting syndrome
Abstract
Abstract Cyclic vomiting syndrome (CVS) is a disorder of gut–brain interaction frequently associated with migraine, suggesting overlapping neurobiological mechanisms. However, therapeutic options remain limited in refractory adult patients. Calcitonin gene-related peptide (CGRP) plays a central role in migraine pathophysiology and is also involved in visceral sensory processing, nausea, and autonomic regulation, supporting a potential therapeutic role for CGRP-targeted therapies in selected CVS phenotypes. We report a 51-year-old woman with adult-onset migraine-associated CVS refractory to multiple preventive therapies, including amitriptyline, venlafaxine, and topiramate. Preventive treatment with the CGRP ligand monoclonal antibody fremanezumab resulted in a marked reduction in migraine frequency and substantial improvement in vomiting severity and frequency, with significant functional recovery over six months of follow-up. This observation supports the hypothesis that CGRP modulation may benefit selected patients with migraine-associated CVS and highlights the need for further systematic evaluation of CGRP-targeted therapies in disorders of gut–brain interaction.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.